Colin M. Clancy

An <i>in vitro</i> and <i>in vivo</i> disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists

Lisa M. Eubanks, Mark S. Hixon, Wei Jin et al. · Proceedings of the National Academy of Sciences · 2007 · 123 citations · Full text

Pharmacy, Molecular Biology, Toxicology +17

Bimodal modulation of the botulinum neurotoxin protein-conducting channel

Audrey Fischer, Yuya Nakai, Lisa M. Eubanks et al. · Proceedings of the National Academy of Sciences · 2009 · 91 citations · Full text

Medicine, Neuroscience, Pharmacology +16

A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies

Sabine Pellett, William H. Tepp, Colin M. Clancy et al. · FEBS Letters · 2007 · 87 citations · Full text

Medicine, Neurology, Pharmacology +14

Good Manufacturing Practice Strategy for Antibody–Drug Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation AJICAP

Yutaka Matsuda, Colin M. Clancy, Zhala Tawfiq et al. · ACS Omega · 2019 · 36 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Analytical Comparison of Antibody-drug Conjugates Based on Good Manufacturing Practice Strategies

Zhala Tawfiq, Yutaka Matsuda, Melody Jane Alfonso et al. · Analytical Sciences · 2020 · 32 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +17